Evolve BioSystems Secures $9,000,000 Series A Funding Round

  • Feed Type
  • Date
  • Company Name
    Evolve BioSystems
  • Mailing Address
    3354 Laguna Street San Francisco, CA 94123 USA
  • Company Description
    Evolve Biosystems will develop and bring to market the next generation of probiotic-based biotherapeutics to establish, restore, and maintain a healthy human microbiome across a range of unmet clinical needs.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series A
  • Proceeds Purposes
    This investment is timely, as it will accelerate our efforts to move these new discoveries into commercial products that can improve the health outcomes for infants globally.
  • M&A Terms
  • Venture Investor
    Horizons Ventures
  • Venture Investor

Trending on Xconomy